Voya Financial Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.9M | Sell |
12,813
-1,264
| -9% | -$194K | 0.19% | 50 |
|
|
2025
Q4 | $1.96M | Sell |
14,077
-41
| -0.3% | -$5.37K | 0.19% | 51 |
|
|
2025
Q3 | $1.75M | Sell |
14,118
-221
| -2% | -$27K | 0.17% | 57 |
|
|
2025
Q2 | $1.72M | Buy |
14,339
+46
| +0.3% | +$5.18K | 0.17% | 58 |
|
|
2025
Q1 | $1.61M | Sell |
14,293
-95
| -0.7% | -$10.1K | 0.18% | 59 |
|
|
2024
Q4 | $1.4M | Buy |
14,388
+742
| +5% | +$79.1K | 0.15% | 62 |
|
|
2024
Q3 | $1.58M | Buy |
13,646
+633
| +5% | +$71.8K | 0.17% | 55 |
|
|
2024
Q2 | $1.39M | Buy |
13,013
+568
| +5% | +$57K | 0.16% | 60 |
|
|
2024
Q1 | $1.19M | Buy |
12,445
+1,309
| +12% | +$134K | 0.14% | 70 |
|
|
2023
Q4 | $1.11M | Buy |
11,136
+391
| +4% | +$37.7K | 0.13% | 67 |
|
|
2023
Q3 | $1.1M | Buy |
10,745
+397
| +4% | +$40.3K | 0.14% | 60 |
|
|
2023
Q2 | $1.03M | Sell |
10,348
-476
| -4% | -$47.6K | 0.12% | 65 |
|
|
2023
Q1 | $991K | Sell |
10,824
-1,199
| -10% | -$105K | 0.12% | 68 |
|
|
2022
Q4 | $1.1M | Sell |
12,023
-2,424
| -17% | -$204K | 0.14% | 62 |
|
|
2022
Q3 | $1.11M | Buy |
14,447
+603
| +4% | +$50K | 0.14% | 71 |
|
|
2022
Q2 | $1.17M | Buy |
13,844
+1,803
| +15% | +$158K | 0.15% | 68 |
|
|
2022
Q1 | $1.06M | Buy |
12,041
+1,796
| +18% | +$156K | 0.12% | 85 |
|
|
2021
Q4 | $896K | Buy |
10,245
+203
| +2% | +$16.9K | 0.1% | 105 |
|
|
2021
Q3 | $832K | Buy |
10,042
+91
| +0.9% | +$8.19K | 0.1% | 104 |
|
|
2021
Q2 | $914K | Sell |
9,951
-34,792
| -78% | -$3.1M | 0.12% | 94 |
|
|
2021
Q1 | $3.89M | Buy |
44,743
+3,037
| +7% | +$273K | 0.15% | 114 |
|
|
2020
Q4 | $3.94M | Sell |
41,706
-1,866
| -4% | -$163K | 0.17% | 101 |
|
|
2020
Q3 | $3.79M | Sell |
43,572
-2,394
| -5% | -$207K | 0.19% | 84 |
|
|
2020
Q2 | $4.01M | Buy |
45,966
+1,577
| +4% | +$136K | 0.21% | 78 |
|
|
2020
Q1 | $3.63M | Buy |
44,389
+2,990
| +7% | +$267K | 0.2% | 79 |
|
|
2019
Q4 | $3.91M | Buy |
41,399
+1,506
| +4% | +$135K | 0.19% | 93 |
|
|
2019
Q3 | $3.49M | Buy |
39,893
+3,635
| +10% | +$326K | 0.19% | 97 |
|
|
2019
Q2 | $3.3M | Sell |
36,258
-3,027
| -8% | -$256K | 0.18% | 105 |
|
|
2019
Q1 | $3.37M | Sell |
39,285
-4,129
| -10% | -$331K | 0.2% | 100 |
|
|
2018
Q4 | $3.32M | Buy |
43,414
+2,221
| +5% | +$173K | 0.22% | 95 |
|
|
2018
Q3 | $3.18M | Buy |
41,193
+6,476
| +19% | +$479K | 0.19% | 105 |
|
|
2018
Q2 | $2.27M | Buy |
34,717
+117
| +0.3% | +$8.07K | 0.15% | 130 |
|
|
2018
Q1 | $2.52M | Buy |
34,600
+2,371
| +7% | +$180K | 0.17% | 131 |
|
|
2017
Q4 | $2.43M | Buy |
32,229
+3,421
| +12% | +$258K | 0.16% | 134 |
|
|
2017
Q3 | $2.19M | Sell |
28,808
-1,057
| -4% | -$79.8K | 0.15% | 133 |
|
|
2017
Q2 | $2.25M | Buy |
29,865
+465
| +2% | +$33K | 0.16% | 123 |
|
|
2017
Q1 | $1.97M | Buy |
29,400
+5,903
| +25% | +$393K | 0.15% | 131 |
|
|
2016
Q4 | $1.52M | Buy |
23,497
+4,669
| +25% | +$303K | 0.13% | 140 |
|
|
2016
Q3 | $1.34M | Buy |
18,828
+2,397
| +15% | +$175K | 0.14% | 128 |
|
|
2016
Q2 | $1.2M | Buy |
16,431
+2,750
| +20% | +$190K | 0.14% | 124 |
|
|
2016
Q1 | $889K | Sell |
13,681
-891
| -6% | -$60.6K | 0.12% | 138 |
|
|
2015
Q4 | $1.14M | Buy |
14,572
+643
| +5% | +$51.1K | 0.17% | 99 |
|
|
2015
Q3 | $1.12M | Buy |
13,929
+294
| +2% | +$26.2K | 0.2% | 91 |
|
|
2015
Q2 | $1.2M | Sell |
13,635
-153
| -1% | -$14K | 0.21% | 84 |
|
|
2015
Q1 | $1.25M | Buy |
+13,788
| New | +$1.22M | 0.24% | 97 |
|
Other funds holding NVS
Voya Financial Advisors's NVS Position: Q1 2026 in Review
Voya Financial Advisors reduced its Novartis (NVS) stake by 9% in Q1 2026, selling an estimated $194K and leaving 12,813 shares worth $1.9M. The position accounts for 0.19% of the portfolio, ranked #50.
Voya Financial Advisors first reported a position in NVS in Q1 2015 and has held it in 45 quarters since. The position peaked at $4.01M in Q2 2020. 1,591 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Voya Financial Advisors held 12,813 shares of Novartis worth $1.9M as of Q1 2026.
- Voya Financial Advisors sold 1,264 Novartis shares in Q1 2026, an estimated $194K.
- Novartis made up 0.19% of Voya Financial Advisors's portfolio in Q1 2026, its #50 holding.
- Voya Financial Advisors first reported a position in Novartis in Q1 2015 and has held it in 45 quarters since.
- Voya Financial Advisors's Novartis position peaked at $4.01M in Q2 2020.
- 1,591 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Voya Financial Advisors's 13F filing for Q1 2026, filed 12 May 2026.